Health Care · Health Care Services
Quest Diagnostics: revenue, profit and dividends
In fiscal 2025, Quest Diagnostics had revenue of $11B, up 3.9% a year on average since 2015, and net income of $992M (9.0% of revenue). Its dividend per share has gone up 15 years in a row, to $3.20. It has 22% fewer shares than in 2015.
Revenue, fiscal 2025
average annual revenue growth since 2015 · +11.8% vs 2024
- Ticker
- DGX · NYSE
- Sector
- Health Care
- Sub-industry
- Health Care Services
- Headquarters
- Secaucus, New Jersey
- Founded
- 1967
- In the S&P 500 since
- December 12, 2002
- Latest fiscal year
- 2025, ended December 31, 2025
- SEC filer
- Quest Diagnostics Inc · CIK 0001022079
Revenue and net income
Revenue went from $6.7B in 2007 to $11B in 2025.
Diluted earnings per share
Diluted EPS went from $1.74 in 2007 to $8.75 in 2025. Ten-year growth: 6.0% a year.
Dividends per share
Raised 15 years in a row, every year from 2011 to 2025. Ten-year growth: 7.7% a year.
Shares outstanding
22.1% fewer shares in 2025 than in 2015 (145M → 113M): buybacks outweighed new shares.
Operating cash flow, capex and free cash flow
Free cash flow (operating cash flow minus capital expenditure) was $1.36B in 2025, 12.3% of revenue.
The chart data could not be loaded. The table below has the same figures.
Year by year
| Fiscal year | Revenue | Net income | Net margin | Diluted EPS | Dividend | Shares | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $11B | $992M | 9.0% | $8.75 | $3.20* | 113M | $1.89B | $527M | $1.36B |
| 2024 | $9.87B | $871M | 8.8% | $7.69 | $3.00* | 113M | $1.33B | $425M | $909M |
| 2023 | $9.25B | $854M | 9.2% | $7.49 | $2.84* | 113M | $1.27B | $408M | $864M |
| 2022 | $9.88B | $946M | 9.6% | $7.97 | $2.64* | 118M | $1.72B | $404M | $1.31B |
| 2021 | $10.8B | $2.0B | 18.5% | $15.55 | $2.48* | 128M | $2.23B | $403M | $1.83B |
| 2020 | $9.44B | $1.43B | 15.2% | $10.47 | $2.24* | 136M | $2.0B | $418M | $1.59B |
| 2019 | $7.73B | $858M | 11.1% | $6.28 | $2.12* | 136M | $1.24B | $400M | $843M |
| 2018 | $7.53B | $736M | 9.8% | $5.29 | $2.03* | 139M | $1.2B | $383M | $817M |
| 2017 | $7.4B | $772M | 10.4% | $5.50 | $1.80 | 140M | $1.18B | $252M | $923M |
| 2016 | $7.21B | $645M | 8.9% | $4.51 | $1.65 | 142M | $1.12B | $293M | $823M |
| 2015 | $7.49B | $709M | 9.5% | $4.87 | $1.52 | 145M | $821M | $263M | $558M |
| 2014 | $7.43B | $556M | 7.5% | $3.81 | $1.32 | 145M | $944M | $308M | $636M |
| 2013 | $7.15B | $849M | 11.9% | $5.54 | $1.20 | 153M | $652M | $231M | $421M |
| 2012 | $7.38B | $556M | 7.5% | $3.46 | $0.81 | 160M | $1.19B | $182M | $1.0B |
| 2011 | $7.39B | $471M | 6.4% | $2.92 | $0.47 | 160M | $895M | $161M | $734M |
| 2010 | $7.26B | $721M | 9.9% | $4.05 | $0.40 | 177M | $1.12B | $205M | $913M |
| 2009 | $7.46B | $729M | 9.8% | $3.87 | $0.40 | 188M | $997M | $167M | $830M |
| 2008 | $7.25B | $581M | 8.0% | $2.96 | $0.40 | 196M | $1.06B | $213M | $850M |
| 2007 | $6.7B | $340M | 5.1% | $1.74 | $0.40 | — | $927M | $219M | $708M |
Fiscal years, labelled by the year in which they end. US dollars; per-share figures and share counts adjusted for splits. —: not in the data. * added up from quarterly reports.
About these figures
- Dividends per share for 2018–2025 are added up from the quarterly reports.
- Older years are as filed at the time and may predate later restatements, mergers or spin-offs. How the figures are made.
Other Health Care Services companies
Source: SEC EDGAR (company filings), data as of November 8, 2026. Sectors, sub-industries, headquarters and index dates: Wikipedia, CC BY-SA 4.0.